Diketo-piperazine and piperidine derivatives as antiviral agents
This disclosure provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with diketo piperazine and piperadine derivatives that possess unique antiviral activity useful for the treatment of HIV and AIDS. More particularly, the present disclosure relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, wherein: A is selected from the group consisting of:
1. A compound selected from the group consisting of:
2. A pharmaceutical composition which comprises an antiviral effective amount of a compound of Formula I, or pharmaceutically acceptable salts thereof, as claimed in claim 1 , and one or more pharmaceutically acceptable carriers, excipients or diluents.
3. The composition of claim 2 , further comprising a second compound having anti-HIV activity.
4. The pharmaceutical composition of claim 2 , useful for treating infection by HIV, which additionally comprises an antiviral effective amount of an AIDS treatment agent selected from the group consisting of:
(a) an AIDS antiviral agent;
(b) an anti-infective agent;
(c) an immunomodulator; and
(d) HIV entry inhibitors.
5. A method for treating a mammal infected with HIV comprising administering to said mammal an antiviral effective amount of a compound of Formula I, or pharmaceutically acceptable salts thereof, as claimed in claim 1 , and one or more pharmaceutically acceptable carriers, excipients or diluents.
6. The method of claim 5 , comprising administering to said mammal an antiviral effective amount of a compound of Formula I in combination with an antiviral effective amount of an AIDS treatment agent selected from the group consisting of: an AIDS antiviral agent; an anti-infective agent; an immunomodulator; and an HIV entry inhibitor.